ArticleThe Journal of biological chemistry2017
A unique structural domain in
Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Diversity-driven biochemical survey reveals widespread dimerization throughout the rubisco superfamily.Nature communications · 2026Article
- Layered entrenchment maintains essentiality in the evolution of Form I Rubisco complexes.The EMBO journal · 2025Article
- Engineering Rubisco to enhance COSynthetic and systems biotechnology · 2024Review
- Deep-branching evolutionary intermediates reveal structural origins of form I rubisco.Current biology : CB · 2023Article
- The small subunit of Rubisco and its potential as an engineering target.Journal of experimental botany · 2023Review
- Interspecies Comparison of Interaction Energies between Photosynthetic Protein RuBisCO and 2CABP Ligand.International journal of molecular sciences · 2022Article
- An Insight of RuBisCO Evolution through a Multilevel Approach.Biomolecules · 2021Article
- Novel bacterial clade reveals origin of form I Rubisco.Nature plants · 2020Article
- Article
- The Prodigal Compound: Return of Ribosyl 1,5-Bisphosphate as an Important Player in Metabolism.Microbiology and molecular biology reviews : MMBR · 2019Review
- A short history of RubisCO: the rise and fall (?) of Nature's predominant COCurrent opinion in biotechnology · 2018Review
- A peptide adhesive molded by magnesium glues Rubisco's subunits together.The Journal of biological chemistry · 2017Article
- Synthetic COBiotechnology for biofuels · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The catalytic inefficiencies of the CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.